Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06735924

Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis

Non Alcoholic Fatty Liver Disease and Endogenous Oxalate Synthesis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
28 (estimated)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims to determine the daily rate of endogenous synthesis of oxalate using fasted urine collection and a low-oxalate controlled diet in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Detailed description

Urinary oxalate excretion is derived from both dietary sources and endogenous synthesis. This study will use a low-oxalate controlled diet, repeat fasted urine collections and 24-hr urine collections on a low-oxalate diet, to determine the daily rate of endogenous oxalate synthesis in individuals with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLow-oxalate fixed dietIngestion of a low-oxalate (\< 60 mg/day) , normal calcium (800-1200 mg/d) eucaloric diet for 5 days

Timeline

Start date
2023-04-26
Primary completion
2026-12-31
Completion
2027-12-31
First posted
2024-12-16
Last updated
2025-12-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06735924. Inclusion in this directory is not an endorsement.